In order to expand the promise of regenerative medicine using allogeneic induced pluripotent stem cells (iPSCs). precise and efficient genome editing of human leukocyte antigen (HLA) genes would be advantageous to minimize the immune rejection caused by mismatches of HLA type. However. clinical-grade genome editing of multiple HLA genes in human iPSC lines remains unexplored. https://proozya.shop/product-category/joggers/